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by

ADANI PUJADA ALCALA

Under the Direction of Didier Merlin, PhD

ABSTRACT
Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) that causes chronic
inflammation and ulcers affecting the innermost layer of the colon. Almost 1 million people
suffer from UC in the United States. UC patients have an increased risk of colitis associated
cancer (CAC). It is driven by continuous exposure to inflammation and progresses through
“dysplasia-carcinoma axis”. Notch1 signaling is a conserved intracellular signaling pathway. It
regulates cell fate, proliferation, differentiation, and death. However, Notch1 acts as a mediator
or suppressor depending on the cellular context and disease stage. Aim of this study is to
understand the mechanistic role of Notch1 in acute colitis and CAC. We used WT mice (control
group) and crossed them with villin-cre mice to generate NCre, which cannot express Notch1 in
colon epithelium. Acute colitis was induced with dextran sodium sulfate (DSS) for five days and

in recovery period, mice were given water after the completion of DSS cycle. CAC was induced
by intraperitoneal injection of azoxymethane and two cycles of DSS. Enteroids were isolated
from six weeks old NCre and WT mice to study proliferation and differentiation. Inhibition of
Notch1 compromised epithelial crypt architecture, led to higher number of goblet cells, and
compromised intestinal barrier function at the basal level. Notch1 mediated inflammation in
DSS- induced acute colitis by increasing inflammatory cytokine levels and activating NF-kB
pathway. In the acute colitis model following a recovery period, Notch1 promoted wound
healing. In CAC, NCre mice showed higher susceptibility to inflammation as indicated by
histology, higher number of polyps, and defective barrier function compared to WT mice.
Western blot data showed increased p53 and cleaved caspase-3 expressions while decreased
expressions of γ-H2AX and MLH1. Notch1 mediates acute colitis by cross-talking with NF-kB
pathway and promoting abnormal proliferation. However, during the recovery period after acute
colitis, Notch1 promotes wound healing. Inhibition of Notch1exarcebates CAC condition due to
lower levels of non-mutated p53 expression. Therefore, this study suggests that Notch1 inhibitors
might be a better option as therapeutics only for acute colitis patients and induction of Nocth1
signaling as a therapy, can protect against chronic colitis/CAC.

INDEX WORDS: Ulcerative colitis, Notch1 signaling, Colitis associated cancer, Tumor
suppressor, Acute inflammation, Chronic inflammation
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1
1.1

GENERAL BACKGROUND

Inflammatory bowel disease
Inflammatory bowel disease (IBD) is an incurable chronic inflammatory condition that

affects the gastrointestinal (GI) tract [1, 2]. Around 3.1 million adults, in the United States, have
being diagnosed with IBD [3]. This disease affects the quality of life, bringing substantial
morbidity and complications that require hospitalizations and surgeries [4] . The exact cause of
this disease is yet not known but studies appoint it to be hereditary, to environmental factors, or
to abnormal immune responses [5]. There are two major forms of IBD: Crohn’s disease (CD)
and Ulcerative colitis (UC). Both share similar symptoms; however, they also have remarkable
differences in the location of inflammation and progression in the GI tract. CD commonly affects
the small intestine, proximal colon, and all the layers of the GI tract, while UC is characterized
by continuous inflammation of the rectal and colonic mucosal layers of the GI tract.
1.1.1 Ulcerative colitis
UC leads to epithelial barrier dysfunction affecting major components of the GI tract
such as epithelial cells, goblet cells, immune cells, and commensal flora [1, 6]. In UC, due to
inflammation, epithelial cell integrity is compromised resulting in the continuous stimulation of
the mucosal immune system and the dysregulation of colonic permeability [7]. Permeability
dysregulation allows the influx of pathogenic foreign substances and the efflux of immune cells
leading to the development of chronic inflammation and then ulceration [8]. Due to this
dysfunction, inflammatory responses inhibit the repair of tissue damage to fix mucosal
homeostasis. Inflammation in short term can be a beneficial response; however, prolong
inflammation can contribute to create a potential tumorigenic microenvironment [9].
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1.2

Colitis associated cancer

Figure 1. CAC progression (above) vs. CRC progression (below).
CAC progresses from dysplasia to adenocarcinoma, while CRC develops from adenoma
to carcinoma.

Patients with chronically active UC have a 15- 40% risk of developing colon associated
cancer (CAC) due to the long duration of the inflammation in the colon [4]. CAC is a subtype of
colorectal cancer, but several features make CAC specific and distinct from sporadic colorectal
cancer (CRC) [10, 11]. While CRC develops from adenoma to carcinoma, CAC develops from
dysplastic tissues among chronically active UC patients (Figure 1) [12]. CAC also presents a
higher number of polyps in the distal colon region compared to CRC [8]. In CAC, chronic
inflammation nurtures the tumor microenvironment and initiates carcinogenesis. Indeed, chronic
inflammation favors to the secretion of proinflammatory cytokines, such as IL-1β, TNF-α, and
IL-6, which promote the accumulation of reactive oxygen species (ROS) and maintains a proinflammatory environment favorable for oncogene activation and tumor suppressor gene
mutations, activation of abnormal proliferation and differentiated anti-apoptotic pathways [10].
This disrupts the colonic epithelial homeostasis exposing the epithelial mucosa and adjacent cells
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to inflammatory luminal content. This is followed by the alteration of immune responses, DNA
damage, and mutations in DNA damage response genes [13-15].
1.3

Notch signaling
1.3.1 Notch family receptors
The Notch gene was first identified in Drosophila melanogaster and encodes a 300kD

type I transmembrane receptor [16, 17]. Notch signaling is a conserved mechanism that controls
a variety of cell fates and developmental pathways in different organisms that range from sea
urchins to humans [18, 19]. In mammals, Notch proteins comprise a family of four receptors
(Notch1-4) whose activity is controlled by Delta-like 1 (Dll1), Dll3, Dll4 and Jagged 1 (Jag1)
and Jag2 family ligands [20-22]. The mutation of the Notch receptor has resulted in
developmental abnormalities and in human pathologies as well [23, 24].
1.3.2 Notch1 structure and activation

Figure 2. Notch1 protein domain structure.
Abbreviations used are: ANK, ankyrin repeats; c, cleavage site at site 1,2 and 3;
EGF, epidermal growth factor; HD, heterodimerization domain; LNR, Lin-Notch
repeats; NRR, negative regulatory region; PEST, proline (P), glutamic acid (E),
serine (S) and threonine (T) degradation domain; RAM, Rbp-associated molecule
domain; SP, signal peptide; TAD, transactivation domain; TM, transmembrane
domain. Adapted from (Jan Mašek and Andersson, 2017).

Notch1 contains four regions: a) extracellular epidermal growth factor (EGF)-like
domains b) the negative regulatory region composed by three cysteine-Lin repeats and the
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heterodimerization domain, c) the transmembrane domain, d) Notch intracellular domain (NICD)
which contains a RBPjκ association module (RAM) domain, seven ankyrin repeats, a
transcription activation domain, and a transactivation domain containing degrons which regulate
the stability of NICD (Figure 2).
Successful interaction of Notch1 receptor with the ligand, present in the neighboring
cells, is mediated by 11-12 EGF repeats (trans interaction), while inhibitory interaction with the
ligand, expressed in the same cell, is mediated by 24-29 EGF repeats (cis interaction) [25]. The
Notch pathway can be activated canonically and non-canonically [26, 27]. The canonical
signaling is well known to have a role during the early steps of organ development and the
maintenance of cells of the organ [28, 29]. In the colon, Notch1 is required for the maintenance
and differentiation of intestinal stem cells in the colon and maintains the balance between
absorptive (epithelial cells) and secretory lineages (goblet, Paneth, tuft, and enteroendocrine
cells) [30, 31]. Canonical activation of Notch1 results of three cleavages, two extracellular and
one intracellular (Figure 3). The canonically activation starts when any Delta or Jag family
ligand binds to extracellular Notch receptors located on the cell surface. This binding will trigger
a first extracellular cleavage, mediated by furin-like proteases such as convertase, in the transGolgi network. The second extracellular cleavage is mediated by serine proteases or
metalloproteases. Lastly, a third intracellular cleavage is mediated by intracellular γ-secretase
generating the active Notch1 intracellular domain (NICD). NICD translocates to the nucleus
where it forms a complex with transcription regulatory factors (CSL/RBP-J). This complex then
allows the displacement of co-repressors [32] and the recruitment of co-activators [33] that
activate the transcription of target genes such as c-Myc, p53, ARF, and Hes [20, 34, 35].
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Very recently, the non-canonically activation of Notch1 has also been identified and is
found to be involved with physiological and pathological cellular processes [36], such as cancer
[37] and activation of the immune system. This differs from the regular cellular processes driven
by the canonical Notch1 pathway. The non-canonical activation is RBP-Jk independent and
plays an important role in the oncogenesis process in certain cell types. Some of the mechanisms
that can activate Notch1 pathway crosstalk with any pathways such as β-catenin/Wnt signaling,
MAPK, mTOR, etc [26].

Figure 3. Notch1 signaling canonical activation.
Interaction between Notch1 receptor and Notch ligands (Jagged/Delta) triggers two
consecutive proteolytic cleavages by a metalloprotease and the γ-secretase complex. This
generates NICD, which enters the nucleus and displaces corepressors (SMRT and CtBP1) and
recruits the coactivator MAML1 and the acetyltransferase p300, resulting in the transcription
of genes bound to the NICD-RBP-J complex, such as Hes. Adapted schematics (Lobry et al.,
2014; Ranganathan et al., 2011)

1.3.3 Notch1 expression in the colon
Notch1 is highly expressed at the basal crypt of the colon and in the colon lamina propria
cells [38, 39]. Notch1 signaling also orchestrates different biological functions such as cell
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differentiation, proliferation, apoptosis, cell-fate, etc. controlling the organ morphogenesis as well
as tissue homeostasis [20, 21] [40, 41]. Notch1 can activate Hes transcription factor implicated in
the maintenance of progenitor and stem cells; thus, promoting epithelial cell differentiation in the
colon [39]. Because Notch1 plays a critical role in these essential processes in the colon tissue,
the dysregulation of Notch1 can contribute to multiple abnormalities that range from
developmental disorders [42] [43] to inflammation and then cancer [44].

2
2.1

THE ROLE OF NOTCH1 IN ACUTE COLITIS

Introduction
UC is characterized by continuous inflammation of the rectal and colonic mucosal layers

which extends proximally [4]. UC leads to epithelial cell barrier dysfunction affecting GI tract
major components such as epithelial cells, goblet cells, immune cells, and commensal flora [1,
6]. Because of this alteration, inflammatory responses arise to help repair colonic injury and fix
tissue homeostasis.
Intestinal homeostatic renewal of the damaged epithelial monolayer is mediated by a pool
of intestinal stem cells (ISCs) called crypt base columnar cells (CBCs), which are constantly
generating new progenitors. CBCs are found intercalated with Paneth like cells at the crypt of the
colon highly expressing the G protein coupled receptor 5 gene (Lgr5) [45]. Notch1 receptor is
expressed in CBCs promoting active Notch1 signaling in these cells to allow their differentiation
into epithelial cells [46] while also serving as a marker for Lgr5 positive cells.
In UC, goblet cells are decreased or depleted [47-49]. Goblet cells main role is the
secretion of Mucin 2 (MUC2), a component of colonic mucus, which protects the mucus layer,
against luminal stimulants and pathogens. Differentiation of ISCs into goblet cells is facilitated
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by Math1, an antagonistic of Notch1 transcription factor-Hes 1, which promotes the
differentiation of secretory cells into goblet, Paneth, and enteroendocrine cells [50, 51].
The colonic epithelium barrier also acts as a line of defense against foreign antigens such
as toxins and microorganisms [8, 52]. Colonic epithelial integrity is defined by apical junctions
comprising tight junctions (TJs), adherent junctions (AJs), and adjacent colonic epithelial cells
[53, 54]. TJs are apical protein complexes formed by transmembrane proteins, claudins, occludin
and tricellulin. All three are connected to the actin cytoskeleton via zona occludens (ZO). In UC,
epithelial integrity is compromised allowing the influx of pathogenic foreign substances which
are recognized by toll like receptors (TLRs) from macrophages and dendritic cells leading to the
activation of pro-inflammatory cytokines such as TNF-α, interlukin-6 (IL-6), and IL-1β. Notch1
receptor activation has been confirmed in studies done by the induction of synthetic TLRs using
bacterial pathogens suggesting that TLRs can indirectly promote the activation of Notch1 [55].
The immediate repair response to an injured intestinal epithelial layer is the restitution
process of epithelial cells. During this process, local epithelial cells redistribute around the
wound to reseal and restore the continuity of this layer but most importantly to preserve colonic
homeostasis. This first step does not require cell proliferation [56], but it does require other
factors such as cytokines [57, 58], cell adhesion molecules [59], and trefoil factors [56]. Cell
proliferation is required after restitution to replenish the decreased pool of epithelial cells.
Epithelial cell proliferation is induced by the secretion of growth factors [60] from local
epithelial cells and mesenchymal cells close to the injury. Hes-1, a downstream target of Notch1
signaling, drives progenitor cells to differentiate into absorptive epithelial cells.
The pathogenesis of UC tells us that there is loss of the mucosal immune system and
epithelial cell integrity [61], linking the regenerative process disturbance directly with Notch1
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functions in the colon. Therefore, understanding the role of Notch1 in UC can assist in
understating the mechanism by which Notch1 mediates inflammation in UC.
2.2

Materials and Methods
2.2.1 Animal models
All animal procedures were performed in accordance with the Guide for the Care of Use

of Laboratory Animals as described previously [58]. Eight-weeks old, both female and male,
Villincre/+; Notchflox/flox (NCre) and wild-type (WT) C57/B6 background were used in these
studies.
To investigate the role of Notch1 in acute colitis and CAC, epithelial cell-specific
deletion of Notch1 was done using the Cre/Lox system. Mice harboring a floxed promoter region
of the Notch1 gene (Notch1loxP/+) were purchased from The Jackson laboratory. The Notch1 loxP/+
were bred to generate NotchloxP/loxP and were monitored for healthy development and fertility
until maturity. Notch1loxP/loxP were bred with Villin-cre in which ‘cre’, under the control of the
villin promoter, is specifically expressed in epithelial cells to generate Villincre/+ ; Notchflox/flox
(NCre) mice. The Notch1 suppression among NCre mice was identified by using PCR
genotyping using Notch forward primer (5′-GCAGTTGTGCTCCTGAAGAA-3′) and reverse
primer (5′-CGGGCGGCCAGAAAC-3′).
2.2.2 Acute colitis (AC) induction and recovery phase
Eight weeks-old, both female and male, NCre and WT mice were induced with acute
colitis by one cycle of 2% Dextran sodium sulfate (DSS) (MP Biomedicals, Solon, OH) by oral
administration through their drinking water for 5 days (Figure 4). To study the role of Notch1 in
recovery period after acute colitis, another set of mice were treated with one cycle of 2% DSS for
five days and then they were allowed to recover for 7 days. Mice was euthanized on day 12
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(Figure 4). Control group mice, NCre and WT, were given regular water for the same amount of
days. Body weight and stool consistency for all the mice were recorded during both, DSS and
recovery phase.

Figure 4. DSS- induced acute colitis model and DSS-induce colitis recovery model.
Abbreviations used are: D-Day and DSS-Dextran sodium sulfate

2.2.3 Cell culture and wound healing assay
HCT116 cells, colon human carcinoma cells, were cultured with DMEM medium
(GIBCO, Invitrogen) supplemented with 10% FBS (Atlanta Biologicals), and 100 units/ml
penicillin, and 100 mg/ml streptomycin (GIBCO) at 37ᵒC in 5% CO2.
Cells (5 x 105) were seeded in 6 well plates and incubated for 24 hrs. When cells were
70-90% confluent, cells were then transfected with or without NICD DNA construct (a kind gift
from Dr. R. Kopan, University of St. Louis). 24 h after transfection, monolayer was wounded by
scratching method with a sterile pipette tip and images were taken at 0, 24, and 48 hrs by using
Keyence BZ-X700 microscope. Transfection efficiency was done by collecting cell lysates at the
mentioned time points and were probed with anti-NICD (Cell Signaling).
2.2.4 Protein extraction and Western Blot (WB) analysis
Colon mucosal stripping was obtained from NCre and WT mice with and without acute
colitis. Antibodies used were anti-NICD (Cell Signaling), anti-COX-2 (Cayman chemical), anti-
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NFkB (Cell Signaling), anti-iNOS (Millipore), and anti-Cyclin D1 (Santa Cruz Biotechnology).
Goat anti-mouse secondary antibody (Bio-Rad) or goat anti-rabbit secondary antibody (Abcam)
were used. β-tubulin (Sigma-Aldrich) was used as loading control.
2.2.5 Mouse colonoscopy
NCre and WT mice with and without acute colitis were subjected to colonoscopy to
assess the mucosal layer thickness due to inflammation and dysplastic lesions. This was
performed using the colonoscope (Xenon Nova 47S, STORZ).
2.2.6 Hematoxylin and Eosin (H&E) staining and histological score evaluation
Formalin fixed and paraffin embedded colon Swiss rolls from NCre and WT mice with
and without acute colitis were used. Histological scores were evaluated based on inflammationinfiltration of white blood cells, crypt damage, and foci of ulceration in the entire colon [62, 63].
Images were taken using Keyence BZ-X700 microscope at X20 and X40 magnification.
2.2.7 Alcian Blue-Periodic Acid Schiff (AB-PAS) staining
Formalin fixed and paraffin embedded colon Swiss rolls from NCre and WT mice with
and without acute colitis were used. Sections were hydrated and incubated with acetic acid for 3
min. Next, sections were stained with 3% Alcian blue (Sigma-Aldrich). After washing, sections
were incubated with 0.5% periodic acid and then with Schiff reagent (Sigma-Aldrich) at room
temperature. Sections were then hydrated with alcohol, cleared with xylene, and sealed. Images
were taken using Keyence BZ-X700 microscope at X20 magnification.
2.2.8 In-vivo permeability assay
Eight weeks-old age, both female and male, NCre and WT mice were gavaged with
permeability tracer (60 mg/100g body weight of FITC-labeled dextran) (Sigma-Aldrich). Serum
was collected retro-orbitally 4 h after gavage and fluorescence intensity of each sample was
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measured at λex=492 nm; λem= 525 nm by using Synergy 2; BioTek. FITC-dextran
concentrations were determined from standard curves generated by serial dilutions of FITCdextran and permeability was calculated by linear regression of sample fluorescence [64, 65].
2.2.9 Myeloperoxidase (MPO) assay
NCre and WT with and without AC colon tissue samples were homogenized in cold
potassium phosphate buffer (50 mmol/l K2HPO4 and 50 mmol/l KH2PO4, pH 6.0) containing
0.5% hexadecyltrimethylammonium bromide (Sigma-Aldrich). The homogenates were
sonicated, freeze-thawed three times, and centrifuged. MPO activity in the samples was
determined and compared to MPO standard after measuring the absorbance at 450nm [64].
2.2.10 Colonoid extraction
Crypts were isolated from six weeks NCre and WT mice. Crypts were grown to colonoids
[66] on Matrigel (Corning, New York, NY) in a 24 well plate. Then, the growth of colonoids on
the plates, were observed every day and images were taken at X10 and X20 magnification with
ZEISS Primovert AxioCam MRm microscope for days 2, 4, 7, and 9.
2.2.11 RNA extraction and QPCR analysis
Total RNA was extracted from colonic tissues using the RNeasy mini Kit (Qiagen)
according to the manufacturer’s instructions. Then, complementary DNA was generated from the
earlier-described total RNA isolated using the Maxima first-strand complementary DNA
synthesis kit (ThermoFisher Scientific). mRNA expression was quantified by quantitative realtime reverse-transcription polymerase chain reaction using Maxima SYBR green quantitative
polymerase chain reaction Master Mix (ThermoFisher Scientific). The following sense and
antisense primers (Table 1) were used: IL-6, IL-1β, TNF-α, IFN-γ, IL-17, and 16SrRNA. Real-
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time PCR data is presented using the DDCT method and using 36B4 gene levels as the internal
standard.

Table 1. Sequences of the QPCR primers used in the study.

13

2.2.12 Immunofluorescent staining of colon Swiss rolls and colonoids
NCre and WT colon Swiss rolls were formalin fixed and paraffin embedded for
immunofluorescence staining. Colon swiss rolls were deparaffinized and tissue was hydrated
with graded concentration of ethanol. For antigen retrieval, proteinase K (Denville Scientific
Inc.) was used for 1 hr at 37ᵒC. Slides were washed with 0.01% TPBS 3 times for 5 mins.
Endogenous peroxidase activity block and immunostaining was performed according
manufacture’s protocol using the Alexa Fluor™ 488 Tyramide SuperBoost™ Kit, goat antirabbit IgG. Primary antibody used was anti-Lgr5 (Abcam). Colon Swiss rolls were inoculated
with Hoechst 3342, Trihydrochloride, Trihydrate in 1X PBS for 30 mins, washed with 1X PBS,
and finally inoculated with TRITC-phalloidin diluted with 1X PBS for 1 h [67]. Images were
taken with Keyence BZ-X700 microscope at X40.
NCre and WT colonoids were grown on Matrigel for 4 days in Tissuetek chambered
slides (Thermo-Fischer) for immunofluorescence staining. Colonoids were fixed with 4%
paraformaldehyde solution for 2h, washed with 1X PBS, and inoculated with FocusClearTM for
2 nights [68]. Colonoids or Swiss rolls were permeabilized with 2% TritonX100 solution and
washed with IF buffer (0.2% TritonX100, 0.05% Tween 20 in 1X PBS). Blocking buffer (2%
TritonX100, 10% goat serum, and 0.02% sodium azide in 1XPBS) was used and then, colonoids
were inoculated with primary antibody anti-TFF3 (Millipore Sigma), and anti-PCNA (Abcam) in
dilution buffer (0.25% TritonX100, 1% normal serum goat, 0.02% sodium azide in 1X PBS)
overnight. Colonoids were washed with IF buffer and inoculated later with secondary antibody
anti-rabbit Alexa Fluor 488- green (ThermoFisher) for 2 nights. After washing, colonoids were
inoculated with Hoechst 3342, Trihydrochloride, Trihydrate in dilution buffer for 1h, washed
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again with IF buffer, and finally inoculated with TRITC-phalloidin in dilution buffer for 2 h.
Images were taken with Keyence BZ-X700 microscope at X40.
2.2.13 Blood biochemical analysis
Blood samples (100µL) were collected retro-orbitally from, both female and male, NCre
and WT mice. Biochemical analyses were obtained by loading the blood sample in VetScan roter
spins and measuring the chemical parameters by the biochemical analyzer VetScan VS2, Abaxis.
2.2.14 Statistical analysis
All data was expressed as means ± SEM and were compared by Student’s t-test [69]. P
values <0.05 was considered statistically significant.
2.3

Results
2.3.1 Characterization of NCre mice
To study the role of Notch1 in acute versus chronic inflammation in colon, NCre mice

was generated by crossing Notch1loxP/loxP and Villin cre mice (C57/B6 background) in which
“cre” (under the control of the villin promoter, is expressed in colon epithelial cells). Eight
weeks old, both female and male, NCre mice along with their wild type WT mice were used for
these studies. The Notch1 deletion among NCre mice was identified by using PCR genotyping.
Figure 5A-i shows the genotyping result where lanes 2-4 are homozygous NCre mice expressing
only one band (281 bp) while lanes 6, 8, and 9 are heterozygous mice, expressing two bands, the
mutant and the WT (281 and 231 bp, respectively). To confirm Notch1 deletion at protein level,
protein lysates were prepared from NCre and WT mice vital organs such as colon, small
intestine, and liver. Figure 5A ii-iii show the western blot analysis from colon and small intestine
respectively indicating the lack of NICD (Notch1 intracellular domain- cleaved or active Notch1)
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presence in colon (lanes 4-6) and small intestine (lanes 3-4), among NCre mice compared to WT
mice. However, Figure 5A- iv shows presence of Notch1 signaling in the liver of NCre mice
(lanes 4-6).
To assess the histological changes in the colon due to the conditional deletion of Notch1,
H&E staining was performed as described in the methods section. Figure 5B shows the H&E
images indicating disrupted crypt architecture, increased neutrophil infiltration, and a few foci of
ulceration among NCre mice compared to WT mice. Figure 5C is a bar graph representation of
the histological score calculated on three parameters as described in the methods section. The bar
graph shows that NCre mice had a significantly higher histological score (2.6 ± 0.9) compared to
WT mice (0.7 ± 0.6). Notch1 mediates enterocyte population against goblet cells, mucus
secretory cells, during stem cell differentiation in colon [38]. To assess the goblet cell
hyperplasia due to the conditional deletion of Notch1 signaling, AB-PAS staining was
performed. Figure 5D shows AB-PAS images indicating that NCre had more goblet cells as
indicated by red arrows compared to WT mice. Figure 5E is the bar graph representation of the
quantification of goblet cells indicating that NCre mice had a significantly increased percentage
of goblet cells (41.49% ± 1.97) compared to WT mice (25.93% ± 4.84).
To assess the role of Notch1 in maintaining epithelial integrity, 4kD FITC–dextran
uptake assay was performed. Figure 5F shows that epithelial barrier was compromised as NCre
mice showed a higher number of FITC units (33.0 ± 7.8) compared to WT mice (11.8 ± 3.9).
These results together indicate that inhibition of Notch1 signaling compromises epithelial cell
integrity due to higher number of goblet cells and impaired intestinal barrier function.
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Figure 5. Conditional deletion on Notch1 signaling in mice colon leads to the loss of epithelial
crypt architecture, increased goblet cell population, and a defective intestinal barrier function.

NCre mice were generated by using a conditional knockout method of ‘Villin-cre’ system and
WT mice were used as a control. (A) (A-i) Qualitative PCR of the DNA extracted from mice
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tails with the primers designed by the supplier (Jackson Laboratories). Homozygous NCre mice
has one mutant band at 281 bp while heterozygous mice have two bands, the mutant at 281 and
the WT at 231 bp. Lane 1 is 100 bp ladder. Each lane shows blots that were performed loading
(25μg/lane) using whole organ cell lysate of (A-ii) colon (A-iii) small intestine (A-iv) liver
probed with anti-NICD. GAPDH was used as a loading control. (B) H&E staining of NCre and
WT colon Swiss rolls (n=5 per group). H&E images were taken at X20. Magnified view of the
squared area is shown in the right panel of the original picture at X40. (C) Bar graph presentation
of the histological score calculated on three parameters- infiltration of neutrophils, loss of crypt
architecture, and foci of ulceration. (D) NCre and WT colon swiss rolls (n=5 per group) were
stained with AB-PAS. Images were taken at X20 magnification. Red arrows show goblet cell
population. (E) Quantification of goblet cell percentage was obtained by counting goblet cells
per epithelial cell crypt (12 crypts/mice). (F) In vivo permeability was performed by gavaging
NCre and WT mice with 4kD FITC-dextran in PBS (60mg/100g body weight). Then, serum via
retro-orbitally was collected after 4 hrs., and the fluorescence within the blood was measured at
λex=492 nm; λem= 525. Each bar represents mean ± S.E., *p<0.05, ***p<0.001.

2.3.2 Conditional deletion of Notch1 in colonic epithelium compromises epithelial
cell differentiation and proliferation in the colon
To investigate the effects of the absence of Notch1 signaling on stem cell differentiation,
immunofluorescence staining of stem cell marker, Lgr5, was performed using colon Swiss rolls
from NCre and WT mice. Figure 6A shows a higher expression of Lgr5, as indicated by white
arrows, among WT compared to NCre colon crypts. To further see the effect of Notch1 silencing
in colonic stem cell differentiation and proliferation, three dimensional colonoids isolated from
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NCre and WT mice were used as ex vivo model. Figure 6B i-iv shows the images of crypts
growing into colonoids monitored for days 2,4,7, and 9, respectively. Figure 6-iv shows that
crypts isolated from NCre mice differentiated slowly as the colonoids look smaller and less
branched compared to the colonoids from WT mice. Figure 6B-v shows a line graph representing
the measured area of organoids per day and it indicates that NCre colonoids had significantly
decreased area on the days 2,4,7, and 9 compared to WT colonoids. Additionally,
immunofluorescent staining of 4 days old colonoids was performed by probing fixed NCre and
WT colonoids with PCNA (proliferation marker) and TFF3 (goblet cell differentiation marker).
Figure 6C-i shows PCNA staining images indicating less expression among the NCre derived
colonoids compared to WT derived colonoids. Figure 6C-ii shows TFF3 staining images
indicating high expression (as a goblet cell marker) among NCre derived colonoids compared to
WT derived colonoids. Together these data imply that Notch1 signaling plays a critical role in
maintaining the stem cell differentiation and proliferation of epithelial cells in the colon.
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Figure 6. Conditional deletion of Notch1 compromises colonic epithelial cell differentiation
and proliferation.

(A) NCre and WT colon Swiss rolls were probed with anti-Lgr5. FITC as green fluorescence was
used as secondary antibody. (B) Crypts isolated from NCre and WT mice colons were grown on
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Matrigel to form colonoids in 24 well plates. Colonoid formation was observed and images were
captured on (B-i) day 2 and (B-ii) day 4, at X20 magnification, and (B-iii) day 7 and (B-iv) day 9
at X10 magnification. (B-v) Organoid area was measured (6 organoids/ phenotype) by using
ImageJ program and values are shown in X 104cm2. (C) Immunofluorescence staining of the 4
days old NCre and WT derived colonoids, fixed in chambered slides (n=4 wells per group), were
probed with (C-i) anti-PCNA and (C-ii) anti-TTF3. FITC as green fluorescence was used as
secondary antibody. Images are the Z-sections at X40 magnification. DAPI was used to
counterstain nuclei with blue fluorescence and red fluorescence is for actin-phalloidin. Each bar
represents mean ± S.E., *p<0.05, **p<0.01.
2.3.3 NCre mice presents increased levels of biochemical parameters
To evaluate the alteration of biochemical parameters due to the conditional deletion of
Notch1 signaling in vivo, VetScan VS2, a chemistry blood analyzer machine, was used. Blood
samples (100 µL) from NCre and WT mice were collected for biochemical analysis. As shown
on Table 1, this analysis revealed a higher number of the following functional parameters: ALB
(3.6 ± 0.1; 3.96 ± 0.2), ALT (28.8 ± 2.3; 34.4 ± 2.5), GLU (180.8 ± 37; 287.4 ± 37.3), TP (4.52 ±
0.2 4.8 ± 0.1), and AMY (543.8 ± 94.6; 665.2 ± 47.3) among NCre mice compared to WT mice,
respectively. Together this data indicates that the lack of Notch1 expression in the colon, leads to
increased levels of ALB and GLU indicating the inflammation in liver.
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Table 2. Biochemical analysis of NCre and WT mice.
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2.3.4 Nocth1 signaling mediates inflammation in DSS- induced acute colitis
Eight weeks old, both female and male, NCre mice and WT mice were induced with acute colitis
by DSS as described in the methods section. Body weight of mice was monitored throughout the
experiment and mice were euthanized at day 5. Figure 7A shows the body weight change in
percentage indicating a significant increase in body weight among NCre mice compared to WT
mice at day 5 of DSS-induced with colitis. Figure 7B shows colonoscopy images indicating the
thickening of mucosa and bleeding among WT mice compared to NCre mice. To assess
inflammation among NCre and WT mice in acute colitis, MPO assay was performed as
described in the methods section. Figure 7C is the bar graph representation of the MPO activity
of the colon indicating that NCre mice had significantly lower (3.63 ± 0.17) MPO activity
compared to WT mice (7.14 ± 1.18) in acute colitis. To assess the severity of inflammation in
NCre mice induced with colitis, H&E staining was also performed. Figure 7D shows H&E
images indicating crypt architecture damage, infiltration of neutrophils, and loci of ulceration
among WT mice compared to NCre mice in acute colitis. Figure 7E shows AB-PAS images
indicating that NCre had a decreased number of goblet cells but non- significant, as indicated by
red arrows, compared to WT mice in acute colitis. Figure 7F is the bar graph quantification of
goblet cells indicating there was no significant difference in goblet cell population between NCre
mice (37.5 ± 5.3) and WT mice (38.2 ± 3.35) in acute colitis.
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Figure 7. Notch1 signaling mediates inflammation DSS-acute colitis
NCre and WT mice (n=5 each group) were treated with one cycle of 2% DSS for 5 days. Body
weight was monitored every day and mice were euthanized at day 5. (A) Line graph
representation of body weight change in percentage of NCre and WT mice with DSS- induced
acute colitis. (B) Colonoscopy images from WT mice (top panel) and NCre mice (bottom panel)
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with or without induced colitis. (C) Bar graph representation of MPO activity. (D) H&E staining
of colonic Swiss rolls from NCre and WT mice in acute colitis at X20. (E) AB-PAS staining of
colon Swiss rolls from NCre and WT mice with acute colitis. Images were taken at X20
magnification. (F) Quantification of goblet cell was obtained by counting goblet cells per
epithelial cell crypt (12 crypts/mice). Each bar represents mean ± S.E., *p< 0.05, **p< 0.01,
***p< 0.001.
2.3.5 Notch1 signaling modulates cytokines levels in acute colitis
To assess the inflammatory environment, mRNA levels of cytokines that are known to
mediate acute inflammatory progression to acute colitis were measured by qPCR as described in
the methods section. Interestingly, the mRNA levels of IL-6 were significantly low among NCre
mice (7.48 ± 1.4-fold) compared to WT mice (15.08 ± 1.80-fold) (Figure 8A). Figure 8B-E
shows significantly increased mRNA levels of IL-1β (3.27 ± 0.53-fold), TNF-α (2.89 ± 1.10fold), IFN-γ (9.19 ± 2.39-fold), and IL-17 (9.58 ± 0.4.82-fold) among NCre mice compared to
WT mice (1.10 ± 1.04, 1.37 ± 0.42, 1.50 ± 1.36; 1.62 ± 1.57- fold). These results together
indicate that Notch1 signaling mediates DSS-induced colitis and is associated with upregulation
of pro-inflammatory and downregulation of anti-inflammatory cytokines.
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Figure 8. Notch1 signaling modulates inflammatory cytokines levels in acute colitis.

Bar graph representation of qPCR analyses representing mRNA levels of cytokines in colonic
mucosal stripping from NCre and WT mice with acute colitis. Relative change in mRNA levels
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of the cytokines (A) IL-6 (B) IL-1β (C) TNF-α (D) IFN-γ and (E) IL-17 are shown. Each bar
represents mean ± S.E., *p< 0.05, **p< 0.01.
SDSSSSSSSSNotch1 signaling mediates NF-kβ activation in acute colitis
To assess the mechanistic pathway by which Notch1 signaling mediates acute colitis,
western blot (WB) analysis was performed to identify the inflammatory signaling pathways.
Figure 9A shows no significant difference in COX-2 protein levels among both groups. Figure
9B shows negligible levels of i-NOS protein in both groups. Figure 9C and 9D shows decreased
protein levels of NF-kB and its downstream target, Cyclin D1, respectively among NCre mice
(lanes 4-6) compared to WT mice (lanes 1-3). NF-kB is a pro-inflammatory signaling pathway,
regulating the secretion of inflammatory cytokine levels [70] and Cyclin D1 regulates cell cycle
progression [71]. Together these data indicate that Notch1 activates NF-kB inflammatory
pathway promoting abnormal cell proliferation and thereby favoring inflammation in acute
colitis.

Figure 9. Notch1 signaling is associated with increased expression of NF-kB and Cyclin D1 in
acute colitis.
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WB analyses of whole cell protein lysates (25µg/lane) using colon mucosal stripping from NCre
and WT mice with acute colitis. Blots were probed with (A) anti-COX-2 (B) anti-iNOS (C) antiNF-kB and (D) anti-Cyclin-D1. β-tubulin was used as loading control.
2.3.6 Notch1 promotes wound healing
Eight weeks old, both female and male, NCre mice and WT mice induced with acute
colitis by DSS were allowed to recover for 7 days as described in the methods section. Their
body weight was monitored throughout the experiment and mice were euthanized on day 12.
Figure 10A shows that at the end of DSS phase NCre mice had significantly body weight loss
compared to WT mice. However, during recovery phase, NCre mice were unable to recover
compared to WT mice. Figure 10B shows colonoscopy images indicating the increased mucosa
thickening, bleeding, and inflammation among NCre mice (indicated by red arrows) compared to
WT mice after 7 days of recovery. Figure 10C-i shows the histological images indicating that
NCre mice presented increased loss of crypt architecture, neutrophil infiltration, and foci of
ulceration compared to WT mice. Figure 10C-ii is the bar graph representation of the histological
inflammatory score based on three parameters mentioned in the methods section indicating that
NCre mice had a significantly higher histological score compared to WT mice after the recovery
phase. Furthermore, to test the hypothesis that Notch1 signaling indeed promotes colonic wound
healing, colon carcinoma human cell line HCT116 was used and transiently transfected to
overexpress NICD as in vitro model. Wound healing assay was performed as described in the
methods section. Figure 10D-i indicates that NICD overexpression promoted cell migration and
proliferation to heal the wound compared to control cells. Figure 10D-ii shows the quantification
of wound closure indicating that HCT116 cells overexpressing NICD initiated wound closure by
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24 hours (87.3%) compared to control cells (91.5 %). Together these data indicate that Notch1
signaling mediates wound healing at recovery phase following acute colitis.

Figure 10. Notch1 promotes wound healing in the recovery phase following acute colitis.
NCre and WT mice (n=5 each group) were treated with one cycle of 2% DSS for 5 days and
went under a recovery phase for 7 days. Body weight was monitored every day and mice were
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euthanized at day 12. (A) Line graph representation of body weight change in percentage of
NCre and WT mice during one cycle of DSS and one recovery phase. (B) Colonoscopy images
from WT mice (top panel) water, acute colitis, and recovery phase, respectively. The bottom
panel shows the same treatments for NCre mice. Arrows indicate signs of inflammation and
thickening of mucosa layer. (C) H&E staining of colon cross sections from NCre and WT mice
completed a recovery phase. (C-i) Magnified view of the squared area is shown in the right side
of the original picture at X40 indicating the disrupted architecture of crypts and infiltration of
neutrophils. (C-ii) Bar graph representation of histological score calculated on three parameters:
infiltration of neutrophils, loss of crypt architecture, and foci of ulceration. (D) Wound healing
assay of human colon carcinoma HCT116 cells transfected to overexpressed NICD. (D-i) Cell
proliferation and migration was monitored and images were taken at 0hrs, 24hrs, and 48 hrs. (Dii) Quantification of wound closure was performed by calculating the wound area using ImageJ
program and it is represented as percent initial wound. Data represent the mean ± S.E., *p< 0.05.

2.4

Discussion
UC is a form of IBD causing inflammation and ulcers in the colon either in

segments or completely. The main symptom of active disease is usually constant diarrhea
mixed with blood. UC as its name suggests, affects only the colon and rectum, leaving the
rest of the GI tract unaffected, hence is very different from CD (another form of IBD).
Although UC has no known cause, presumed genetic component and susceptibility to western
diet and lifestyle increases the prevalence of this disease. UC is triggered in a susceptible
person by environmental factors, although dietary modifications may reduce the discomfort
of a person with the disease. Recent Studies of migrant populations as well as populations
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of developing countries ha ve demonstrated a slow but steady increase in the incidence of UC
[72]. The incidence of UC is higher than CD incidence in the United States [73]. UC is
characterized by continuous inflammation throughout the colon affecting the mucosal layer of
the GI tract compromising epithelial cells integrity and increasing the paracellular permeability
allowing the entrance of foreign antigens and microorganisms to the lamina propria [8, 52].
Notch1 signaling is a highly conserved intercellular signal transduction pathway
which is induced upon environmental cues. It is associated with colonic inflammation [26] and
colon cancer [74]. Notch1 is a key player in the differentiation of intestinal stem cells to
epithelial /enterocyte lineage [75]. Notch1 activation requires three cleavages: two extracellular
and one intracellular [35]. Translocation of Notch1 intercellular domain (NICD) to the nucleus
activates downstream targets such as Hes, c-Myc. These downstream targets are directly
involved with differentiation, inflammation, or carcinogenesis pathways [35].
Inflammatory mediators modulate Notch1 signaling and have been documented in acute
colitis. However, the precise mechanistic role of Notch1 signaling in acute colitis is not well
understood. Therefore, in the present study, a conditional Notch1 knockout mice (NCre) lacking
Notch1 expression in colon epithelial cells was generated to identify the role and mechanism of
Notch1 in acute colitis.
We observed that the conditional deletion of Notch1 in colonic epithelial cells resulted in
higher histological score, increased goblet cells population, defective barrier function,
compromised epithelial cell differentiation and proliferation, and liver inflammation at the basal
level. Interestingly, we also observed that silencing of Notch1 signaling attenuated inflammation
in the in vivo DSS-induced acute colitis model as implied by colonoscopy, decreased MPO
levels, and higher histological score. These data together showed less severity of colonic
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inflammation among NCre mice compared to WT mice. Although, in acute colitis the
conditional deletion of Notch1 signaling did not cause goblet cell hyperplasia among NCre mice
compared to WT mice.
Recent studies have found the activation of Notch1 during inflammation. Dysregulated
Notch1 signaling has been associated with inflammatory conditions such as rheumatoid arthritis
[76], systemic lupus erythematosus [77], pre-term labor [78], bacterial infection [79]. Although,
one can also reason that inflammatory cells modulate Notch1 through canonical and noncanonical signaling pathways [80]. Inflammation can stimulate the Notch1 pathway through an
extrinsic stimulus like recognition of pathogen infection toll-like receptors (TLRs) activating
innate immune cells or through an intrinsic stimulus such as immune signaling molecules
(cytokines) [26]. Our data shows that interestingly the conditional deletion of Notch1
significantly decreased mRNA levels of pro-inflammatory cytokine, IL-6, increased mRNA
levels of the pro-inflammatory cytokines: IL-1β, IFN-γ, and TNF-α, while it decreased antiinflammatory cytokines: IFN-γ and IL-17 compared to Notch+/+ mice with acute colitis.
Increased levels of pro-inflammatory cytokine IL-6 among Notch+/+ mice with acute colitis
might be due to the possible non-canonical activation of Notch1 signaling in the cytoplasm to
intrinsically upregulate IL-6 signaling mediating inflammation in acute colitis. compared to WT
mice in acute colitis.
Additionally, there was no difference in the expression of COX-2, an inflammatory
enzyme mediator, in both NCre and WT mice. Several of the transcription factors regulate COX2 are known to be activated by inflammatory cytokines [81] , which explains a low but constant
expression in both NCre and WT mice induced with acute colitis. There was also negligible
expression of i-NOS, which is known to produce nitric oxide that dysregulates inflammatory
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processes and causes tissue injury [82]. However, we observed a significant decrease in NF-kB
protein levels as well as its downstream target cyclin D1 among NCre mice compared to WT in
acute colitis. NF-kB is an inflammatory pathway [83] which regulates the expression of Cyclin
D1. Cyclin D1 is a cell cycle progression marker and regulates cell cycle progression and cell
proliferation [71]. Therefore, this study elucidates that Notch1 signaling mediates acute colitis by
activating NF-kB signaling pathway. Activation of NF-kB promotes the proliferation of inflamed
epithelial cells via its downstream target Cyclin D1 as well as IL-6 secretion (Figure 11).
The epithelial lining of the GI tract continually renews throughout life [84]. This layer
has the capacity of regenerating whenever there is a damage [85]. During UC, the mature
epithelial cell migration (restitution process) and regeneration process (proliferation process) gets
disturbed by the unmanageable progression of inflammation on the mucosal layer. The
restitution process involving local epithelial cells redistribute around the wound to reseal and
restore the continuity of this layer but most importantly to preserve homeostasis of the tissue and
it is mediated by cytokines [57] [58], cell adhesion molecules [59], trefoil factors[56], etc. Cell
proliferation is required after restitution to replenish the decreased pool of progenitor cells that
will later differentiate into mature epithelial cells. This lineage decision and maturation of
epithelial cells is mediated by Notch1 signaling in the GI tract [28, 86]. Although, Notch1
signaling seems to mediate inflammation in DSS-induced acute colitis, we sought to further
investigate its role in the colonic epithelia restitution and regeneration system, in a UC
completed recovery phase model.
Interestingly, we observed an opposite role played by Notch1 signaling during recovery
after acute colitis phase. Notch1 signaling mediated wound healing during recovery phase as
indicated by gain of body weight, and lower historical score among WT mice compared to NCre
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mice. Additionally, our in vitro data suggested that the overexpression of NICD in HCT116 cells
facilitated in the restoration of the scratched-wounded area by the first 24 hrs. Therefore, these
data together imply that Notch1 plays a contrasting role in recovery phase following acute colitis
by enhancing wound healing in the colon.
Our study highlights that Notch1 is critical in the maintenance of epithelial cell integrity,
goblet cell homeostasis, efficient barrier function, epithelial cell differentiation and proliferation
under normal conditions. We also observed the contrasting role of Notch1 in acute colitis versus
a completed recovery phase. Notch1 signaling worsens acute colitis but mediates wound healing
during recovery phase of acute inflammation. Overall, the modulation of Notch1 signaling in this
study confirms the differing role of Notch1 signaling in different settings.
In acute colitis, inflammation causes epithelial-mucosal injury and disrupts the defensive
barrier against pathogenic luminal contents. Therefore, the delicate equilibrium between healthy
epithelial-mucosal restitution versus the removal of inflamed epithelium is lost due to
inflammatory mediators such as cytokines, chemokines, and growth factors. Consequently,
epithelial cells fail to exit the inflammatory stage. Loss of healthy epithelium is the major
challenge in preventing acute colitis to chronic inflammation progression. Therefore, as longterm cure, therapeutics pertinent to epithelial-mucosal restitution are very critical for UC
patients. The beneficial role of Notch1 in wound healing could be translated as an efficient
targeted therapy for UC patients.
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Figure 11. Notch1 signaling mediates inflammation in acute colitis by activating NF-kB
signaling pathway.
Activation of NF-kB signaling pathway promotes the proliferation of inflamed epithelial cells via its
downstream target Cyclin D1 as well as IL-6 cytokine secretion. Abbreviations used are: NICD- Notch1
intracellular domain; S-2,3-Site 2,3.
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3
3.1

THE ROLE OF NOTCH1 IN COLITIS ASSOCIATED CANCER

Introduction
Although acute or short term inflammation may be self-healing, repeated flares of acute

inflammation can cause chronic inflammation and contribute to create a tumorigenic
microenvironment [9] as seen in colitis associates cancer (CAC). Chronic inflammation leads to
the secretion of proinflammatory cytokines, such as IL-1β, TNF-α, and IL-6, which promote the
accumulation of reactive oxygen species (ROS) maintaining a pro-inflammatory environment
favorable for mutations, activation of proliferation and anti-apoptotic pathways [10]. This causes
a disruption of the intestinal homeostasis, inhibition of the proper communication between the
epithelial mucosa and adjacent tissues, an altered immune response, DNA damage, and an
accumulation of mutations in DNA repair genes involved in DNA damage response [13, 14, 87].
DNA damage response (DDR) signaling is triggered by DNA double-strand breaks (DSBs)
and it is initiated by phosphatidylinositol-3-like protein kinase ataxia-telangiectasia mutated
(ATM). Then, a complex known as MRN (MRE11, RAD50, and NBS1) is formed and localized
to the DSBs together with ATM. After this recruitment, a lysine acetyltransferase 5 (Tip60) binds
ATM directly which induces its activity and the acetylation of ATM, an early step of ATM
activation. The phosphorylation of histone H2AX is critical for signal amplification and
recruitment of DDR factors at DNA lesions. This signal is further amplified by the engagement of
downstream checkpoint kinases, CHK1 and CHK2, cell-cycle checkpoint components [88].
FOXO3a has also been proposed to bind to ATM upon DNA damage and to be necessary for its
activation [89]. DDR signaling comprises different pathways and one of them is the mismatch
repair (MMR) pathway. MMR role is to repair base-base mismatches and insertion/deletions loops
arising from replication errors. Two key proteins in this system are the MutS and MutL families.
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MutS is comprised by MSH2 and MSH6 proteins and MutL is comprised by MLH1 and PMS1
proteins. Complexes (MutS/MutL) interact with each other to orchestrate a recruitment of
downstream repair proteins, such as proliferating cell nuclear antigen (PCNA) , to execute DNA
repair [90].
Complete remission of CAC would require the elimination of inflammation as well as the
repair of damaged epithelium. Epithelial repair can be done by organized steps of restitution,
proliferation, and differentiation of epithelial cells. Recent studies have focused in Notch1
signaling because of its role in cell proliferation, differentiation, and self-destruction processes.
Studies have shown that disruption of transcription factors downstream of Notch1 signaling,
such as Hes1, in mice results in the depletion of intestinal epithelial cells [30, 50, 91].
Administration of a pharmacological Notch1 inhibitor results in an increase number of goblet
cells in mice intestine, providing the evidence that Notch1 regulates the linage decision of
epithelial cells [92, 93]. However, this regulation in a chronic inflammation environment has yet
to be studied.

Notch1 signaling function has been found to be context dependent in different cell types
and tissue context, at different developmental stages, and under normal versus pathological
conditions. Notch1 can be oncogenic or tumor suppressive, this means that it can promote irregular
differentiation in some tissues [94] or it can help maintain stem cells homeostasis in others [95].
Its oncogenic role was first illustrated in 1991 where Notch1 was suspected to be related to the
development of T-cell acute lymphocytic leukemia (T-ALL)/lymphoma [96]. Studies have shown
that activated Notch1 can induce neoplastic transformation in mouse mammary and salivary glands
and in rat kidney cells in vitro [97-99]. Another study mentions that Notch signaling is required
for the neoplastic transformation in Ras-transformed human breast cancer cells [98]. Studies in
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mice have shown that Notch1 signaling in sporadic colon cancer (CRC) is also oncogenic and it is
required for adenoma formation due to the elevated Wnt signaling that occurs in adenomatous
polyposis coli/multiple intestinal neoplasia (ApcMin) mice model of colon cancer [28, 44, 100,
101]. Moreover, activated Notch1, via β-catenin, has the oncogenic role in promoting primary
melanoma cells progression [102].
However, different studies have shown that Notch1 is not exclusively oncogenic, it can
also act as a tumor suppressor depending on the inflammatory stimulus and context. For example,
Liu et al have shown that deletion of Notch1 in one allele leads to vascular tumors and massive
hemorrhage in the liver and it is associated with decreased mice survival suggesting a Notch1
tumor suppressive function [95]. Another study using Notch1-deficient mice, in epidermis and
corneal epithelium, developed basal-cell-carcinoma like tumors after being chemical-induced for
carcinogenesis, again suggesting a tumor suppressor role in the mammalian skin [103]. Notch1
also functions as a tumor suppressor by inhibiting the tumor growth of mouse prostate cancer cells
[104] and small cell lung cancer cells [105]. It was previously shown that inhibition of Notch1 by
the γ-secretase inhibitor DAPT (N- [N-(3,5 difluorophenacetyl)-1-alanyl 1]-S-phenylglycine tbutyl ester) reduces apoptosis and promotes CAC. As previously mentioned, different groups have
also shown that Notch1 has a protective role in a variety of malignancies such as as prostate cancer
[104], cervical cancer [106, 107] and skin cancer [103]. However, the precise mechanism of action
of Notch1 signaling in CAC remains unclear. Therefore, understanding the mechanistic role of
Notch1 would assist in the identification of key proteins and signaling pathways that are critical to
treat CAC development. Additionally, this could also bring a direct treatment to prevent cancer in
UC patients.
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3.2

Materials and Methods
3.2.1 Colitis associated cancer (CAC) induction
Ten weeks old, both female and male, NCre and WT mice were injected intraperitoneally

with Azoxymethane (AOM) (7.6 mg/kg) (Sigma-Aldrich), a cancer inducer, on day 0. On day 7,
both mice groups were exposed to 2% DSS (w/v) (MP Biomedicals, Solon, OH) by oral
administration through their drinking water for 7 days. On day 14, their water was changed to
regular drinking water. On day 28, a second cycle of 2% DSS was administered to both groups
and after a week DSS was changed to regular drinking water and mice were euthanized on day
56 (Figure 12). Body weight and stool consistency of all mice was monitored during DSS and
recovery phase.

Figure 12. AOM/DSS- induced colitis associated cancer (CAC) model.
Abbreviations used are: D-Day, AOM- Azoxymethane, and DSS-Dextran sodium sulfate.

3.2.2 Protein extraction and Western blot (WB) analysis
Colon mucosal stripping was obtained from NCre and WT mice with and without CAC.
Antibodies used were anti-NICD (Cell signaling), anti-p53 (Cell Signaling), anti-Cleaved
caspase 3, (Cell Signaling), anti-p21WAF1/Cip1 (BD Biosciences), anti-γH2AX (Abcam), and antiMLH1 (Abcam). Goat anti-mouse secondary antibody (Bio-Rad, Hercules, CA) or goat antirabbit secondary antibody (Abcam) were use. β-tubulin (Sigma-Aldrich) or GAPDH (Abcam)
were used as loading control.
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3.2.3 Mouse colonoscopy
NCre and WT mice with and without CAC were subjected to colonoscopy to assess the
mucosal layer thickness due to inflammation and dysplastic lesions. This was performed using
the colonoscope (Xenon Nova 47S, STORZ).
3.2.4 Hematoxylin and Eosin (H&E) staining and histological score evaluation
Formalin fixed and paraffin embedded colon Swiss rolls from NCre and WT mice with
and without CAC were used. Histological scores were evaluated based on inflammationinfiltration of white blood cells, crypt damage, and foci of ulceration in the entire colon. Images
were taken using a Keyence BZ-X700 microscope at X20 and X40 magnification.
3.2.5 Alcian Blue- Periodic Acid Schiff (AB-PAS) staining
Formalin fixed and paraffin embedded colon Swiss rolls from NCre and WT mice with
and without CAC were used. Sections were hydrated and incubated with acetic acid for 3 min.
Next, sections were stained with 3% Alcian blue (Sigma-Aldrich). After washing, sections were
incubated with 0.5% periodic acid and then with Schiff reagent (Sigma-Aldrich) at room
temperature. Sections were then hydrated with alcohol, cleared with xylene, and sealed. Images
were taken using a Keyence BZ-X700 microscope at X20 magnification.
3.2.6 Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)
staining
Paraffin sections of colons were deparaffinized and apoptotic cells were identified by
immunofluorescent terminal deoxynucleotidyl transferase–mediated deoxyuridine triphosphate
nick-end labeling (TUNEL) staining using In Situ Cell Death Detection Kit (Millipore-Sigma),
Fluorescein according to the manufacturer’s instructions. Quantification of apoptosis was
performed by counting the number of apoptotic cells in a crypt and was shown as percentage.
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3.2.7 In vivo-permeability assay
Ten weeks-old age, both female and male, NCre and WT mice treated with or without
CAC were gavaged with permeability tracer (60 mg/100g body weight of FITC-labeled dextran)
(Sigma-Aldrich). Serum was collected retro-orbitally 4 h after gavage and fluorescence intensity
of each sample was measured at λex=492 nm; λem= 525 nm by using Synergy 2; BioTek. FITCdextran concentrations were determined from standard curves generated by serial dilutions of
FITC-dextran and permeability was calculated by linear regression of sample fluorescence.
3.2.8 Myeloperoxidase (MPO) assay
NCre and WT with and without CAC colon tissue samples were homogenized in cold
potassium phosphate buffer (50 mmol/l K2HPO4 and 50 mmol/l KH2PO4, pH 6.0) containing
0.5% hexadecyltrimethylammonium bromide (Sigma-Aldrich). The homogenates were sonicated
(40% amplitude), freeze-thawed three times and centrifuged (4ᵒC at 14,000 rpm). MPO activity
in the samples was determined and compared to MPO standard (Sigma-Aldrich) after measuring
the absorbance at 450nm.
3.2.9 RNA extraction and QPCR
Total RNA was extracted from colonic tissues using the RNeasy mini Kit (Qiagen)
according to the manufacturer’s instructions. Then, complementary DNA was generated from the
earlier-described total RNA isolated using the Maxima first-strand complementary DNA
synthesis kit (ThermoFisher Scientific). mRNA expression was quantified by quantitative realtime reverse-transcription polymerase chain reaction using Maxima SYBR green quantitative
polymerase chain reaction Master Mix (ThermoFisher Scientific). The following sense and
antisense primers (Table 1) were used: TNF-a, S1008A, S100A9, and 16SrRNA. Real-time PCR
data is presented using the DDCT method and using 36B4 gene levels as the internal standard
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3.2.10 Statistical analysis
All data was expressed as means ± SEM and were compared by Student’s t-test [69]. P
values <0.05 was considered statistically significant.

3.3

Results
3.3.1 Conditional deletion of Notch1 in colonic epithelium increases CAC
susceptibility
Ten weeks old, both male and female, NCre and WT mice were induced with CAC as

described in the methods section. Body weight was monitored throughout the experiment and
mice were euthanized at day 56. Figure 13A shows the body weight change in percentage
indicating that NCre mice had a significant decrease in body weight at the end of week 5 and
week 6 compared to WT mice in CAC. Figure 13B shows a bar graph representation of colon
length indicating that there was a significant decrease in colon length among the NCre mice
compared to WT mice in CAC. Figure 13C shows colonoscopy images indicating that NCre
mice presented flat polyps, thickened mucosa, and inflammation compared to WT mice in CAC.
Figure 13D shows the quantification of the polyps indicating that there was indeed a significant
number of polyps on NCre mice (7.2 ± 1.75) compared to WT mice (4.0 ± 0.82) in CAC. Figure
13E shows the histological images of colon Swiss rolls indicating increased infiltration of
inflammatory cells, an extensive loss of crypt architecture, increased foci of ulceration, and
dysplasia among NCre mice compared to WT mice in CAC. Figure 13F is the bar graph
representation of the histological score based on the criteria as mentioned in the methods section.
The bar graph indicated that NCre mice presented significantly higher histological score (9.4 ±
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1.38) compared to WT mice (7.29 ± 1.11) in CAC. Together these data indicate that deletion of
Notch1 signaling in the colon exacerbates CAC condition.

Figure 13. Conditional deletion of Notch1 in colonic epithelium results in increased
susceptibility to CAC.
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NCre and WT mice (n=7 each group) were treated with one AOM intraperitoneal injection and 2
cycles of 2% DSS to induce CAC. Body weight were monitored throughout the experiment and
mice were euthanized at day 56. (A) Line graph representation of body weight change of NCre
and WT (B) Bar graph representation of colon length among NCre mice and WT mice in CAC.
(C) Colonoscopy images from WT mice (top panel) and NCre mice (bottom panel). Arrows
indicate polyps, the thickening of mucosa, and inflammation. (D) Bar graph representation of
number of polyps among NCre mice and WT mice in CAC. (E) H&E staining of colon Swiss
rolls from NCre mice and WT mice in CAC. Left panel shows images at X10 and right panel at
X20. (F) Bar graph presentation of the histological score calculated on three parametersinfiltration of neutrophils, loss of crypt architecture and foci of ulceration. Each bar represents
mean ± S.E., *p< 0.05, **p<0.01, ***p< 0.001.
3.3.2 Notch1 signaling modulates cytokine levels, maintains epithelial cell integrity
and barrier function, and maintains the microbiome population
Chronic inflammation favors the secretion of pro-inflammatory cytokines and damagedassociated molecular pattern molecules (DAMPs) nurturing the tumor microenvironment that can
progress to carcinogenesis and metastasis [108, 109]. The mRNA expression level of proinflammatory cytokine, TNF-α, and damage-associated molecular pattern (DAMP) molecules,
such as S100A8 and S100A9, were measured by performing QPCR. Figure 14A shows the
significantly increased levels of TNF-α among NCre mice (2.36 ± 1.13-fold) compared to WT
mice (0.64 ± 0.09-fold) in CAC. Figure 14B interestingly shows no significant difference in
mRNA levels of S100A8 in both NCre mice (4.11 ± 2.78-fold) compared to WT mice (1.34 ±
0.47-fold) in CAC. However, Figure 14C shows significantly decreased levels of S100A9 among
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NCre mice (1.22 ± 0.60-fold) compared to WT mice (2.59 ± 0.65) in CAC. In the setting of
chronic inflammation, the epithelial barrier function is compromised which worsens CAC
conditions, resulting in the downregulation of the microbial population. Epithelial barrier
function was assessed by gavaging mice with 4kD FITC-dextran. Figure 14D shows significantly
increased number of FITC units among NCre mice (39.5 ± 8.6) compared to WT mice (23.9 ±
3.12) in CAC. Figure 14E shows decreased levels of 16SrRNA (universal bacteria primer) among
NCre mice (1.73 ± 0.8-fold) compared to WT mice (3.21 ± 0.24-fold) in CAC. Together these
data indicate that conditional deletion of Notch1 promotes the secretion of pro-inflammatory
cytokine, TNF-α, and impairs epithelial cell integrity and microbiota population in CAC.
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Figure 14. Conditional deletion of Notch1 increases cytokine levels and disrupts
colonic epithelia cell barrier function in CAC.
NCre and WT mice (n=7 each group) were treated with one AOM intraperitoneal injection and 2
cycles of 2% DSS to induce CAC. Bar graph representation of qPCR analyses representing

46

mRNA levels of cytokine and DAMP molecules, in colonic mucosal stripping from NCre and
WT mice in CAC, respectively. (A) TNF-α (B) S100A8 and (C) S100A9. (E) In vivo
permeability was performed by gavaging NCre and WT mice with 4kD FITC-dextran in PBS
(60mg/100g body weight). Then, serum via retro-orbitally was collected after 4 hrs, and the
fluorescence within the blood was measured at λex=492 nm; λem= 525. (D) Bar graph
representation of qPCR analysis representing mRNA levels of 16SrRNA. Each bar represents
mean ± S.E., *p< 0.05, **p< 0.01, NS= non-significant.
3.3.3 Notch1 signaling activates tumor suppressor p53 and downstream target
p21WAF1/Cip1 increasing apoptosis and decreasing DDR and MMR proteins in
CAC
The secretion of pro-inflammatory cytokines, under chronic inflammation, promotes the
accumulation of reactive oxygen species (ROS), promoting a pro-inflammatory environment
favorable for oncogene activation and tumor suppressor gene mutations. NICD, the cleaved
cytoplasmic domain of Notch1, can translocate to the nucleus and activate tumor suppressor
transcription factors, such as p53 which also happens to be the first gene mutation to appear in
CAC. Therefore, to identify the mechanistic pathway by which Notch1 signaling acts as a tumor
suppressor in CAC, protein lysates from the colon mucosal stripping were used for western blot
analysis as described in the methods section. Figure 15A-i confirms the lack of NICD protein
expression (lanes 4-6) among NCre mice compared to WT mice (lanes 1-3) in CAC. Figure 15Aii indicates the absence of p53 protein among NCre mice (lanes 4-6) compared to WT mice
(lanes 1-3) in CAC. ROS accumulation, due to chronic inflammation, can produce DNA damage,
accelerate cancer cell growth, and alter anti-apoptotic pathways increasing mutations in DNA
response (DDR) and mismatch repair (MMR) genes, which are two important cellular events for
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the maintenance of healthy epithelium [10, 13-15, 110]. To assess apoptosis in CAC, TUNEL
staining was performed in the colonic epithelium. Figure 15B shows the overlay image
indicating that there was a significant decrease in apoptosis, as indicated by white arrows, among
NCre mice compared to WT mice in CAC. Further, to confirm the activation of apoptosis
associated proteins, Caspase-3 and p21WAF1/Cip1, in CAC, WB analysis was performed. Figure
15C shows decreased protein level of cleaved caspase-3 among NCre mice (lanes-3-5) compared
to WT mice (lanes 1-2) in CAC. Figure 15D-ii also shows the decreased protein level of
p21WAF1/Cip1 among NCre mice (lanes 4-5) compared to NCre mice (lanes 1-3) in CAC. To assess
the effects of conditional deletion of Notch1 on DDR and MMR proteins in CAC, WB analyses
of γ-H2AX and MLH1 were performed. Figure 15D-i and 14D-iii show higher protein levels of
y-H2AX and MLH1 among NCre mice (lanes 4-5) compared to WT mice (lanes 1-3) in CAC.
Together these data indicate that conditional deletion of Notch1 in colonic epithelium is
associated with lower levels of p53, p21, and apoptosis. Therefore, absence of Notch1 signaling
leads to increase DNA damage and impaired MMR pathway.
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Figure 15. Notch1 exhibits a tumor suppressor role by increasing apoptosis and DDR and
MMR proteins in CAC.
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NCre and WT mice (n=7 each group) were treated with one AOM intraperitoneal injection and 2
cycles of 2% DSS to induce CAC. Western blots of protein from colon mucosal stripping from
NCre and WT mice induced with CAC were used and probed with (A-i) anti-NICD (A-ii)
antip53 and (C) anti-Cleaved caspase-3. (B) The overlay images of green-yellow nuclei
apoptotic cells as indicated by white arrows. Magnification at X20. (D) WB of protein from
colon mucosal stripping from NCre and WT mice induced with CAC were used and probed with
(D-i) anti-γ-H2AX (D-ii) anti-p21WAF1/Cip1 and (D-iii) anti-MLH1. β-actin or GAPDH was used
as a loading control and each lane shows (25ug/lane) from an individual mouse.
3.4

Discussion
Chronic inflammation increases the risk for developing cancer. It is known that patients

with chronically active UC have a 15-40% risk of developing CAC due to the long duration of the
inflammation in the colon [4]. CAC progresses from dysplastic tissue to adenoma and it is different
from colorectal cancer (CRC) progression. CRC progression starts from adenoma to carcinoma
stage. Chronic inflammation environment is a complex network involving different cell types,
inflammatory cytokines, signaling molecules, extracellular matrices, etc. that work together to start
carcinogenesis. Indeed, chronic inflammation favors to the secretion of proinflammatory
cytokines, such as IL-1β, TNF-α, and IL-6, which promote the accumulation of reactive oxygen
species (ROS) and maintains a pro-inflammatory environment favorable for oncogene activation
and tumor suppressor gene mutations, activation of abnormal proliferation and differentiated antiapoptotic pathways [10]. This disrupts the colonic epithelial homeostasis and ruptures the normal
communication between the epithelial mucosa and adjacent tissues, alters immune responses, leads
to DNA damage, and mutations in DNA response (DDR) genes worsening CAC condition [1315].
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The mammalian receptor, Notch1, which is highly expressed at the basal crypt of the
human colon [38], is known for stem cell renewal, progenitor cell-fate determination, terminal
differentiation of proliferating cells, and tissue homeostasis in the healthy colon [20, 21, 38, 40].
Notch1 activation leads to the transcription of downstream target genes, such as hairy enhancer of
split 1 (Hes1), which is critical in the lineage decision for progenitor cells to differentiate in colonic
epithelial cells [39, 111]. Studies have defined Notch1 role to be context dependent, it can be
oncogenic [96, 97] or tumor suppressive [112], therefore, it can promote irregular differentiation
in some tissues [94] or it can help maintain stem cells homeostasis in others [95].

Its oncogenic role was first illustrated in 1991 where Notch1 was suspected to be related
to the development of T-cell acute lymphocytic leukemia (T-ALL)/lymphoma [96]. Studies have
shown that activated Notch1 can induce neoplastic transformation in mouse mammary and salivary
glands and in rat kidney cells in vitro [97-99]. Another study mentions that Notch signaling is
required for the neoplastic transformation in Ras-transformed human breast cancer cells [98].
Studies in mice have shown that Notch1 signaling in CRC is also oncogenic and it is required for
adenoma formation due to the elevated Wnt signaling that occurs in adenomatous polyposis
coli/multiple intestinal neoplasia (Apc Min) mice model of colon cancer [28, 44, 100, 101].
However, different studies have shown that Notch1 is not exclusively oncogenic, in fact it can also
act as a tumor suppressor. Liu et al. have shown that chronic inhibition of Notch1 leads to vascular
tumors in the liver and it is associated with decreased survival suggesting the tumor suppressive
role of Notch1 [95]. Another study using Notch1-deficient mice, in epidermis and corneal
epithelium, developed basal-cell-carcinoma like tumors after being chemical-induced for
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carcinogenesis, again suggesting a tumor suppressor role in the mammalian skin [103]. Notch1
also functions as a tumor suppressor by inhibiting the growth of mouse prostate cancer cell [104].
It has been previously shown that inhibition of Notch1 by the γ-secretase inhibitor DAPT
(N- [N-(3,5 difluorophenacetyl)-1-alanyl 1]-S-phenylglycine t-butyl ester) reduces apoptosis
during CAC [113]. Although, in recent years, different studies have reported the protective role of
Notch1 in various malignancies however, the underlying precise mechanism Notch1 signaling in
CAC remains unclear. Understanding the role of Notch1 in CAC is critical and will assist in
unraveling novel efficient therapeutics to prevent carcinogenesis in the chronically inflamed colon
tissue. We hypothesized that Notch1 acts as a tumor suppressor in CAC by activating tumor
suppressor p53 [114] and p21 (downstream target of p53) by regulating cell cycle progression for
DNA repair of damaged cells. In this study, we observed that conditional deletion of Notch1
signaling exacerbated CAC conditions as indicated by the shortening of colon length, increased
dysplastic lesions, mucosa thickening, increased number of polyps, loss of crypt architecture,
increased infiltration of white blood cells, and higher histological score. These all represent
severity of CAC under chronic inflammatory colonic conditions. Moreover, our data shows that
the conditional deletion of Notch1 promoted the secretion of pro-inflammatory cytokine, TNF-α,
which is one of the cytokines critical in nurturing tumor environment in CAC.
Damage-associated molecular pattern molecules (DAMP) contribute significantly in
mediating inflammation, modulating tumor growth and metastasis [109]. Interestingly, we
observed that mRNA level of the DAMP molecule, S100A8, was no different between both
groups, however, S100A9 mRNA level was increased in Notch+/+ mice compared to NCre mice
in CAC. Further, the reason why S100A9 might be high in Notch+/+ mice could be due to the
recent discovery from LI et al. mentioning that S100A9 has several putative p53 binding sites

52

meaning that its overexpression can induce apoptosis in a p53 dependent manner [115]. This was
also supported by the p53 WB analysis in our study indicating increased p53 protein expression
among WT mice compared to NCre mice in CAC. Our data supports the fact that, conditional
deletion of Notch1 in CAC, disrupts the colonic epithelial cell integrity compromising epithelial
cell barrier as indicated by the increase number of FITC units compared to Notch+/+ mice. This
impaired barrier function and epithelial integrity results in the decreased of microbiota
population among NCre mice compared to WT mice. Therefore, our data elucidates that
conditional deletion of Notch1 results in microbiota depletion causing an imbalance epithelial
homeostasis and favoring chronic inflammation in CAC.
Disruption of the colonic epithelial homeostasis leads to the increase in DNA damage and
for damaged epithelial cells to evade apoptosis. Critical cellular events, such as DRR and MMR,
activate to the rescue to repair and replenish healthy epithelial cells in the damaged tissue. Our
data shows that the conditional deletion of Notch1 is associated with lower levels of tumor
suppressor- p53 and apoptosis associated protein- p21WAF1/Cip1 while it increases DDR sensorsγH2AX and MMR protein-MLH1 indicating that Notch1 signaling absence increases DNA
damage, decreases apoptosis, and compromises DDR and MMR pathways. In conclusion, we
demonstrate that Nocth1 plays a tumor suppressor role in CAC, by activating p53 and p21 and
by promoting DDR and MMR activity to maintain healthy colonic epithelial cells over
inflamed/damaged ones (Figure 16).
Tissue specific deletion of Notch1 in colonic epithelium worsened CAC conditions. Both,
epithelial injury and lack of epithelial healing, favor chronic inflammation progression to
dysplasia. Epithelial injury is primarily caused due to the ROS generation during chronic
inflammation. Therefore, as an efficient and long-term preventive strategy for CAC, therapeutic
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interventions are required to limit the chronic inflammation at the initial stages. This window is
very critical to avoid the extensive and irreversible damage caused by the inflammatory
environment leading to cancer in CAC. Overall, activation of Notch1 in the early stages of
chronic inflammation could be an efficient preventive therapeutic strategy for CAC progression.

Figure 16. Notch1 plays a tumor suppressor role in CAC.
Notch1 signaling plays a tumor suppressor role in CAC by activating p53 and downstream
target p21 and by promoting DDR and MMR activity to maintain healthy colonic epithelial
cells over inflamed/damaged ones. Abbreviations used are: NICD-Notch intracellular
domain, S2-S3-Site2 and Site3; TJ-Tight junction; ROS- Reactive oxygen species; MMRMismatch Repair pathway
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3.5

Conclusion
IBD is a chronic condition that involve dysregulated immune response and inflammation

of the gastrointestinal (GI) tract [1, 6]. UC is a form of IBD that affects the rectum and
inflammation also spreads throughout the colon affecting the inner layer of the colon as well as
the mucosa. Patients with active UC have a 15-40% risk of developing colitis associated cancer
(CAC) due to the longterm inflammation in the colon [4]. CAC is a subtype of colorectal cancer
which develops from dysplasia to carcinoma axis among chronically active UC patients [10-12].
Notch1 is highly expressed at the basal crypt of the human colon [38] and it plays a role
in stem cell renewal, progenitor cell-fate determination, terminal differentiation of proliferating
cells, and tissue homeostasis in the colon [20, 21, 38, 40]. Notch1 activation can be multifaceted,
depending on the severity of the disease, Notch1 can be protective or deleterious. Previous
studies have found that Notch1 has a beneficial role in corneal and skin healing while it is
deleterious in breast cancer [116-118]. Interestingly, Notch1 has been found to be upregulated in
early stages of cervical cancer; whereas, it is downregulated in late stages of cervical cancer
[119-121]. Notch1 signaling can activate cancer associated transcription factors such as, c-Myc,
ARF and p53 [122]. It can also activate Hes transcription factor implicated in the maintenance of
progenitor and stem cells; thus, promoting epithelial cell differentiation in the colon [39].
Therefore, Notch1 function is context dependent, it can be oncogenic or tumor suppressive. It
was previously shown that pharmacological inhibition of Notch1 decreases apoptosis and
promotes CAC progression during the disease [113]. In recent years, different groups have also
shown that Notch1 has a protective role in a variety of malignancies such as prostate cancer
[104], cervical cancer [106, 107] and skin cancer [103]. However, the precise mechanism of
Notch1 signaling in acute colitis and CAC remains unclear.
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In this study, we sought to explore the role of Notch1 through different stages of colitis,

starting from acute inflammation to CAC. Understanding the role of Notch1 will assist in the
improvement for treatments to prevent carcinogenesis in chronically inflamed colon tissues. We
hypothesized that Notch1 activation mediates inflammation in acute colitis; however, it plays a
protective role during CAC. This hypothesis was addressed by two aims which can potentially 1)
target inflammatory pathways which mediate acute inflammation via Notch1 activation 2) bring
a more specific treatment to prevent the development of cancer in IBD patients.
To study the role of Notch1 in acute colitis and CAC, we generated a conditional knockout
mouse (NCre) using the Cre/Lox system. NCre mice do not express Notch1 in epithelial cells.
The first section of this dissertation goes over the characterization of NCre mice. We showed that
the conditional deletion of Notch1 leads to higher numbers of goblet cells and compromises
epithelial crypt architecture and colonic barrier function. We also showed that the conditional
deletion of Notch1 compromises epithelial cell differentiation and proliferation in the colon. In
addition, biochemical blood analytes showed significantly higher among NCre mice indicating
that there was inflammation in their livers compared to the control mice.
Next, we explored if Notch1 activation mediates inflammation in acute colitis. By using a
DSS- induced colitis model, we showed that Notch1 mediates inflammation in acute colitis as it
upregulates pro-inflammatory (IL-6) and downregulates anti-inflammatory (IFN-γ) cytokines.
Notch1 activation in DSS-induced model also activated NF-kB-Cyclin D1 inflammatory
pathway which promotes proliferation favoring inflammation in acute colitis. Notch1 is known
for its role in colonic stem renewal, progenitor-cell fate determination, and tissue homeostasis;
therefore, we also wanted to explore the role of Notch1 in wound healing in the recovery phase
following acute colitis. By using a DSS-induced colitis recovery model and HCT116 cells
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transfected to overexpress NICD, we showed that Notch1 indeed promotes wound healing in the
recovery phase following acute colitis. Therefore, Notch1 signaling plays an opposite role as it
protected the mice, during the recovery phase, from mediating inflammation.
In CAC, chronic inflammation leads to the secretion of proinflammatory cytokines, which
promotes the accumulation of ROS and maintains a pro-inflammatory environment favorable for
oncogenes and mutations in tumor suppressor genes. Chronic inflammation dysregulates the
balance between proliferation and apoptotic pathways. Altogether, contribute to the disruption of
intestinal homeostasis [10, 13, 14, 87]. To study the role of Notch1 in CAC, mice were injected
with azoxymethane, a carcinogen, and treated with two cycles of DSS. In the second section of
this dissertation, we showed that the conditional deletion of Notch1 in the colonic epithelium
increases CAC susceptibility by disrupting epithelial cell integrity, barrier, and microbiota
population. We also showed that the conditional deletion of Notch1 promoted the secretion of
pro-inflammatory cytokine, TNF-α, as well as increased DNA damage and decrease in apoptosis.
In addition, Notch1 conditional deletion in colon impaired DDR sensors and MMR pathway.
Therefore, these data suggest that Notch1 acts as a tumor suppressor in chronic colitis.
In conclusion, these results imply that Notch1 activation is context dependent. Depending
on the severity of the disease, in this case acute colitis, we showed that Notch1 is deleterious
during acute inflammation. However, Notch1 activation can be protective during chronic
colitis/CAC. These results could further be translated to a potential therapeutic solution for IBD
patients. Notch1 target inhibitors should be avoided during acute inflammation and the induction
of Notch1 signaling can be protective in CAC.
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